PL3471702T3 - Stabilne formulacje z lipidami bakteriobójczymi - Google Patents

Stabilne formulacje z lipidami bakteriobójczymi

Info

Publication number
PL3471702T3
PL3471702T3 PL17734841T PL17734841T PL3471702T3 PL 3471702 T3 PL3471702 T3 PL 3471702T3 PL 17734841 T PL17734841 T PL 17734841T PL 17734841 T PL17734841 T PL 17734841T PL 3471702 T3 PL3471702 T3 PL 3471702T3
Authority
PL
Poland
Prior art keywords
stable formulation
antimicrobial lipids
lipids
antimicrobial
formulation
Prior art date
Application number
PL17734841T
Other languages
English (en)
Inventor
Sveinbjorn Gizurarson
Helga HELGADOTTIR
Thordis Kristmundsdottir
Original Assignee
Capretto Ehf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Capretto Ehf. filed Critical Capretto Ehf.
Publication of PL3471702T3 publication Critical patent/PL3471702T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0031Rectum, anus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0046Ear
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005Antimicrobial preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicinal Preparation (AREA)
PL17734841T 2016-06-20 2017-06-19 Stabilne formulacje z lipidami bakteriobójczymi PL3471702T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IS050153 2016-06-20
EP17734841.4A EP3471702B1 (en) 2016-06-20 2017-06-19 Stable formulation of antimicrobial lipids
PCT/IS2017/050009 WO2017221275A1 (en) 2016-06-20 2017-06-19 Thermostable formulation of biologically active substances

Publications (1)

Publication Number Publication Date
PL3471702T3 true PL3471702T3 (pl) 2022-05-02

Family

ID=59270072

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17734841T PL3471702T3 (pl) 2016-06-20 2017-06-19 Stabilne formulacje z lipidami bakteriobójczymi

Country Status (11)

Country Link
US (1) US11337949B2 (pl)
EP (1) EP3471702B1 (pl)
AU (1) AU2017283276B2 (pl)
CA (1) CA3028927C (pl)
DK (1) DK3471702T3 (pl)
ES (1) ES2907867T3 (pl)
HU (1) HUE057773T2 (pl)
LT (1) LT3471702T (pl)
PL (1) PL3471702T3 (pl)
PT (1) PT3471702T (pl)
WO (1) WO2017221275A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017221276A1 (en) * 2016-06-20 2017-12-28 Capretto Ehf. Synergistic effects, augmenting antimicrobial effects of lipids
CA3132568A1 (en) * 2019-03-04 2020-09-10 Capretto Ehf. Methoxy polyethylene glycol for microbial removal
EP4044999A1 (en) * 2019-10-16 2022-08-24 Symrise AG Compositions with antimicrobial properties

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1302280C (en) 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
EP0351651B1 (en) 1988-07-21 1993-09-15 F. Hoffmann-La Roche Ag Insulin preparation
US20050043402A1 (en) * 1996-11-14 2005-02-24 Halldor Thormar Methods and formulations for counteracting infection of mucosa or skin
FR2827770B1 (fr) * 2001-07-27 2005-08-19 Gattefosse Ets Sa Composition pharmaceutique a usage oral comprenant un principe actif susceptible de subir un important effet de premier passage intestinal
WO2003070280A2 (en) 2002-02-25 2003-08-28 Lyfjathroun Hf Absorption enhancing agent
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
MX2010001730A (es) * 2007-08-21 2010-03-10 Basilea Pharmaceutica Ag Composicion antimicotica.
GB201010954D0 (en) 2010-06-29 2010-08-11 Edko Pazarlama Tanitim Ticaret Compositions
EP2953455A4 (en) 2013-02-04 2016-07-27 3M Innovative Properties Co ANTIMICROBIAL COMPOSITIONS, WIPES AND METHODS
WO2016022170A1 (en) 2014-08-08 2016-02-11 Novan, Inc. Topical emulsions
WO2017221276A1 (en) * 2016-06-20 2017-12-28 Capretto Ehf. Synergistic effects, augmenting antimicrobial effects of lipids

Also Published As

Publication number Publication date
EP3471702A1 (en) 2019-04-24
AU2017283276B2 (en) 2023-02-16
EP3471702B1 (en) 2021-12-29
US11337949B2 (en) 2022-05-24
ES2907867T3 (es) 2022-04-26
CA3028927C (en) 2024-01-09
AU2017283276A1 (en) 2019-02-07
CA3028927A1 (en) 2017-12-28
HUE057773T2 (hu) 2022-06-28
DK3471702T3 (da) 2022-03-14
LT3471702T (lt) 2022-03-10
WO2017221275A1 (en) 2017-12-28
PT3471702T (pt) 2022-03-17
US20190209511A1 (en) 2019-07-11

Similar Documents

Publication Publication Date Title
IL291055A (en) Stable formulations of lipids and liposomes
IL257279A (en) Anti-Epner 1 formulation is stable
ZA201802719B (en) Treatment compositions providing an antimicrobial benefit
PT3474822T (pt) Formulações de brincidofovir
IL272857A (en) Cofanalisib formulations
PT3582617T (pt) Formulação estável de piridazinpirazolamidas pesticidas
PL3184492T3 (pl) Preparat antyseptyczny
PL3471702T3 (pl) Stabilne formulacje z lipidami bakteriobójczymi
GB201608356D0 (en) Formulation
PT3678644T (pt) Formulações de copanlisib
IL258420A (en) Stable formulations of fingolimod
GB201707615D0 (en) Formulation
PL3559185T3 (pl) Preparat nabłyszczający
GB201609925D0 (en) Formulation
GB201602048D0 (en) Formulation
GB201514384D0 (en) Antimicrobial compositions and uses of antimicrobial pyrazine compounds